Mental disorders in women suffering from frequent forms of secondary amenorrhea: nosographic structure and psychological markers
Suggested citation:
Bobrov AE, Il'ina NA. [Mental disorders in women suffering from frequent forms of secondary amenorrhea: nosographic structure and psychological markers]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2022;(5):74-83. Russian
In this scientific review in order to determine the frequency, nosographic structure and psychological markers of comorbid mental disorders, three previous studies involving patients with secondary amenorrhea were analyzed. The examination data of 69 women with functional hypothalamic amenorrhea, 43 with hyperprolactinemic hypogonadism and 116 with polycystic ovary syndrome were considered. These studies used ICD-10 criteria, MINI-6 interview, as well as the MMPI test. Mental disorders were observed in 65–90% of the surveyed women. Hyperthymic, depressive-dysthymic, anxious-alert, and masculine patterns of behavior were identified, reflecting the increased psychological vulnerability of patients.
Keywords mental disorders; secondary amenorrhea; functional hypothalamic amenorrhea; hyperprolactinemic hypogonadism; hyperprolactinemia; polycystic ovary syndrome; behavior patterns; personality disorders
1. Renuka N, Praveen K, Nayanabai S, et al. Menstrual problems and mental health issues: exploring the propinquity among adolescent girls in private high schools of Mysuru. Int J Community Med Public Health. 2022;9(2):858–62. DOI: https://doi.org/10.18203/2394-6040.ijcmph20220252 2. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6(1):1–13. DOI: https://doi.org/10.2147/CLEP.S37559 3. Schweiger U, Schweiger JU, Schweiger JI. Mental Disorders and Female Infertility. Arch Psychol. 2018;2(6):1–14. DOI: https://doi.org/10.31296/aop.v2i6.73 4. Bhat A, Reed SD, Unützer J. The Obstetrician-Gynecologist’s Role in Detecting, Preventing, and Treating Depression. Obstet Gynecol. 2017;129(1):157–63. DOI: https://doi.org/10.1097/AOG.0000000000001809 5. Sheehan DV, Lecrubier Y, Sheehan KH, et al. M.I.N.I. Russian Translation Version 6.0.0 DSM-IV. Mapi Research Institute, 2010. 32 p. 6. WHO. MKB-10. Klassifikatsiya psikhicheskikh i povedencheskikh rasstroystv. Issledovatelskiye kriterii. Zheneva, Sankt-Peterburg; 1994. 208 p. (In Russ.) 7. Berezin FB, Miroshnikov MP, Sokolova ED. Metodika mnogostoronnego issledovaniya lichnosti. Struktura, osnovy interpretatsii, nekotoryye oblasti primeneniya. Moscow; 2011. 320 р. (In Russ.) 8. Gibson MES, Fleming N, Zuijdwijk C, Dumont T. Where have the periods gone? The evaluation and management of functional hypothalamic amenorrhea. J Clin Res Pediatr Endocrinol. 2020;12(Suppl 1):18–27. DOI: https://doi.org/10.4274/jcrpe.galenos.2019.2019.S0178 9. Gordon CM, Ackerman KE, Berga SL, et al. Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(5):1413–39. DOI: https://doi.org/10.1210/jc.2017-00131 10. Chernukha GE, Bobrov AE, Gusev DV, et al. Psikhopatologicheskiye osobennosti i endokrinno-metabolicheskiy profil patsiyentok s funktsionalnoy gipotalamicheskoy amenoreyey [Psychopathological features and endocrine and metabolic profile in patients with functional hypotalamic amenorrhea]. Akusherstvo i ginekologiya. 2019;(2):105–12. (In Russ.) DOI: https://doi.org/10.18565/aig.2019.2.105-112 11. Brogna P, Caroppo E. The body as a simulacrum of identity: The subjective experience in the Eating Disorders. Ann Ist Super Sanita. 2010;46(4):427–35. DOI: https://doi.org/10.4415/ANN_10_04_11 12. Wildemberg LE, Fialho C, Gadelha MR. Prolactinomas. Presse Med. 2021;50(4):104080. DOI: https://doi.org/10.1016/j.lpm.2021.104080 13. Kredentser JV, Hoskins CF, Scott JZ. Hyperprolactinemia – A significant factor in female infertility. Am J Obstet Gynecol. 1981;139(3):264–7. DOI: https://doi.org/10.1016/0002-9378(81)90006-5 14. Bahamondes L, Faúndes A, Tambascia M, et al. Menstrual pattern and ovarian function in women with hyperprolactinemia. Int J Gynecol Obstet. 1985;23(1):31–6. DOI: https://doi.org/10.1016/0020-7292(85)90007-4 15. Vilar L, Abucham J, Albuquerque JL, et al. Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the neuroendocrinology department of the Brazilian society of endocrinology and metabolism. Arch Endocrinol Metab. 2018;62(2):236–63. DOI: https://doi.org/10.20945/2359-3997000000032 16. Sobrinho LG. Emotional aspects of hyperprolactinemia. Psychother Psychosom. 1998;67(3):133–9. DOI: https://doi.org/10.1159/000012273 17. Kellner R, Buckman MT, Fava M, et al. Prolactin, aggression and hostility: a discussion of recent studies. Psychiatr Dev. 1984;2(2):131–8. PMID: 6483849 18. Sonino N, Navarrini C, Ruini C, et al. Life events in the pathogenesis of hyperprolactinemia. Eur J Endocrinol. 2004;151(1):61–5. DOI: https://doi.org/10.1530/eje.0.1510061 19. Montalvo I, Gutiérrez-Zotes A, Creus M, et al. Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis. PLoS One. 2014;9(2):e89428. DOI: https://doi.org/10.1371/journal.pone.0089428 20. Athanasoulia AP, Ising M, Pfister H, et al. Distinct dopaminergic personality patterns in patients with prolactinomas: A comparison with nonfunctioning pituitary adenoma patients and age-and gender-matched controls. Neuroendocrinology. 2012;96(3):204–11. DOI: https://doi.org/10.1159/000335996 21. Melnichenko GA, Pavlova MG, Kulygina MA, et al. Gruppovaya psikhoterapiya bolnykh s giperprolaktinemicheskim gipogonadizmom. Problemy endokrinologii. 2002;48(5):18–22. (In Russ.) DOI: https://doi.org/10.14341/probl11638 22. Bobrov AE, Melnichenko GA, Pyatnitskiy NYU, Bondarenko MG. Osobennosti psikhicheskogo sostoyaniya bolnykh s pervichnoy giperprolaktinemiyey. Problemy endokrinologii. 1995;41(2):22–5. (In Russ.) DOI: https://doi.org/10.14341/probl11367 23. Teede HJ, Misso ML, Costello MF, et al., International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol. 2018;89(3):251–68. DOI: https://doi.org/10.1111/cen.13795 24. Ozcan Dag Z, Oguzturk O, Isik Y, et al. Personality profile in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2015;31(7):540–2. DOI: https://doi.org/10.3109/09513590.2015.1018162 25. Amiri FN, Tehrani FR, Simbar M, et al. Female gender scheme is disturbed by polycystic ovary syndrome: A qualitative study from Iran. Iran Red Crescent Med J. 2014;16(2):e12423. DOI: https://doi.org/10.5812/ircmj.12423 26. Ilina NA, Bobrov AE, Dovzhenko TV, Grodnitskaya EE. Psikhicheskiye rasstroystva i lichnostnyye osobennosti u patsiyentok s sindromom polikistoznykh yaichnikov [Mental disorders and personality characteristics of patients with polycystic ovary syndrome]. Zh Nevrol Psikhiatr Im SS Korsakova. 2022;122(4):87–93. (In Russ.) DOI: https://doi.org/10.17116/jnevro202212204187
DOI: http://dx.doi.org/10.47877/1560-957Х-2022-10507
Article Metrics
Metrics powered by PLOS ALM